Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials (2023)

First Author: Dawed A
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(22)00340-0

Publication URI: http://dx.doi.org/10.1016/s2213-8587(22)00340-0

Type: Journal Article/Review

Parent Publication: The Lancet Diabetes & Endocrinology

Issue: 1